azithromycin a pharmacological agent which selectively
play

Azithromycin, a pharmacological agent which selectively inhibits - PowerPoint PPT Presentation

Azithromycin, a pharmacological agent which selectively inhibits some pathways of endocytosis: characterization, interests and mechanism of action. Donatienne Tyteca, Pharm. Thesis submitted for the dregree of Doctor in Pharmaceutical Sciences


  1. Azithromycin, a pharmacological agent which selectively inhibits some pathways of endocytosis: characterization, interests and mechanism of action. Donatienne Tyteca, Pharm. Thesis submitted for the dregree of Doctor in Pharmaceutical Sciences (PhD) Promotor: Prof. M.P. Mingeot-Leclercq Copromotors: Profs P.J. Courtoy & P.M. Tulkens Brussels, December 4 th , 2001 D. Tyteca - PhD Thesis December 4th, 2001 1

  2. Endocytosis ➥ ➥ ➥ ➥ mammalian cells take up extracellular material by a variety of mechanisms collectively termed endocytosis ➥ ➥ implications of endocytosis in physiology: ➥ ➥ ● uptake of extracellular nutrients, ● ● ● ● cellular cholesterol homeostasis, ● ● ● ● regulation of hormonal response, ● ● ● ● maintenance of cell polarity, ● ● ● ● antigen presentation, ● ● ● ● .... ● ● ● ➥ implications of endocytosis in pathology: ➥ ➥ ➥ ● ● atherosclerosis, ● ● ● ● entry of pathogens and toxins, ● ● ● ● neurogenerative diseases (Alzheimer, prion), ● ● ● ● .... ● ● (Mukherjee et al, 1997) D. Tyteca - PhD Thesis December 4th, 2001 2

  3. Pathways of endocytosis studied in this thesis pinocytosis phagocytosis zipper non-coated trigger coated pit pit recycling compartment early phagosome sorting endosome late late phagosome endosome D. Tyteca - PhD Thesis December 4th, 2001 lysosome 3

  4. Membrane lipids are implicated at various stages of the endocytic process membrane organization in domains membrane asymmetry membrane fluidity D. Tyteca - PhD Thesis December 4th, 2001 4

  5. Molecular machineries of endocytic pathways membrane coat proteins: cytoskeleton adhesion to a budding tension and clathrin, APs curved particle asymmetry COPs fission dynamin transport actin microtubules docking fusion Rab SNARE/SNAP PI 3-kinase membrane acidification H + H + vacuolar H + H + H + -ATPase D. Tyteca - PhD Thesis December 4th, 2001 5

  6. What is the place of pharmacological inhibitors to dissect the endocytic apparatus ? Conditions, mutations and agents have been extensively used to dissect cellular mechanisms of endocytosis: ➥ ➥ ➥ ➥ conditions: ● K+ depletion (Cupers et al, 1994) ● ● ● ● incubation in hypertonic medium (Cupers et al, 1994; 1997) ● ● ● ● cytosol acidification (Sandvig et al, 1987) ● ● ● ➥ ➥ mutants: ➥ ➥ ● clathrin, adaptor proteins and associated proteins ● ● ● ● COP ● ● ● ● dynamin ● ● ● ● Rabs ● ● ● ● .... ● ● ● (for a review, see Dautry-Varsat, 2001) D. Tyteca - PhD Thesis December 4th, 2001 6

  7. chlorpromazine benzyl alcohol ➥ ➥ ➥ ➥ agents: membrane coat proteins: cytoskeleton adhesion to a budding tension and clathrin, AP curved particle asymmetry COP fission dynamin cytochalasins transport actin wortmannin gentamicin microtubules nocodazole docking fusion Rab SNARE/SNAP PI 3-kinase membrane acidification H + H + H + -ATPase phospholipi H + H + dosis chloroquine bafilomycins D. Tyteca - PhD Thesis December 4th, 2001 7

  8. limitations: ➥ ➥ ➥ ➥ almost all are unspecific and show pleiotropic effects ➥ ➥ none inhibit the earliest steps of clathrin-independent pinocytosis ➥ ➥ and azithromycin ? D. Tyteca - PhD Thesis December 4th, 2001 8

  9. Azithromycin (AZ), a dicationic amphiphile 9a CH 3 N H 3 C CH 3 9 OH OH 3' H 3 C OH CH 3 (H 3 C) 2 N H 3 C HO H 3 CH 2 C O O O CH 3 1 O O H 3 CO CH 3 CH 3 O H 3 C OH D. Tyteca - PhD Thesis December 4th, 2001 9

  10. Pharmacological properties of AZ ➥ ➥ ➥ ➥ spectrum of activity ● Gram + ● ● ● ● some Gram - ● ● ● ➥ ➥ therapeutic use ➥ ➥ ● upper and lower respiratory tract infections ● ● ● ● skin infections ● ● ● ● sexually transmitted diseases ● ● ● ● Mycobacterium avium complex in AIDS patients ● ● ● ➥ ➥ ➥ ➥ pharmacokinetic properties in vivo ● exceptionally high and rapid accumulation in tissues, and ● ● ● slow release (Foulds et al, 1990) ● consequences ● ● ● ➥ ➥ ➥ low serum concentrations ➥ ➥ ➥ ➥ ➥ decrease of the length of treatment ➥ toxicity ??? Pharmacological properties of AZ ➥ ➥ ➥ D. Tyteca - PhD Thesis December 4th, 2001 10

  11. Cellular pharmacokinetic properties of AZ ➥ accumulates in lysosomes of fibroblasts and macrophages (Carlier et al, 1994) ➥ ➥ ➥ ➥ ➥ acidotropic sequestration (de Duve et al, 1974) ➥ ➥ Extracellular Extralysosomal space fluid Lysosomes B B B H + H + H + BH + BH + BH + D. Tyteca - PhD Thesis December 4th, 2001 11

  12. Cellular toxicological properties of AZ ➥ induces a lysosomal phospholipidosis in fibroblasts (Van Bambeke et al, 1996) ➥ ➥ ➥ ➥ ➥ ➥ ➥ inhibits lysosomal phospholipase A1 (Montenez et al, 1996) D. Tyteca - PhD Thesis December 4th, 2001 12

  13. ➥ ➥ ➥ ➥ binds to negatively-charged bilayers at acidic pH (Montenez et al, 1996) ➥ ➥ ➥ ➥ perturbs the fusion of lysosomes with horseradish peroxidase (HRP)-containing endosomes (unpublished observation of Van Bambeke) D. Tyteca - PhD Thesis December 4th, 2001 13

  14. ➀ Could AZ affect earlier steps of the endocytic apparatus ? ➀ ➀ ➀ Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase endocytosis in cultured fibroblasts D. Tyteca, P. Van Der Smissen, F. Van Bambeke, K. Leys, P.M. Tulkens, P.J. Courtoy & M.-P. Mingeot-Leclercq Eur. J. Cell Biol. 80: 466-478 (2001) ● Selection of experimental system ● ● ● Rat foetal fibroblasts ➥ ➥ avidly accumulate azithromycin ➥ ➥ ➥ ➥ develop lysosomal phospholipidosis ➥ ➥ ➥ ➥ ➥ ➥ extensively characterized system ● Experimental test ● ● ● Fluid-phase endocytosis D. Tyteca - PhD Thesis December 4th, 2001 14

  15. Fluid-phase endocytosis ➥ horseradish peroxidase (HRP) ➥ ➥ ➥ zipper HRP trigger non-coated coated pit (a) pit (Cupers et al, 1994) recycling compartment early phagosome (b) sorting endosome late late phagosome endosome lysosome D. Tyteca - PhD Thesis December 4th, 2001 15

  16. ● General experimental protocol ● ● ● confluent cells pretreatment with AZ (from 0 to 3 days) incubation with the endocytic tracer (from 0 to 4 h) washing, recovering and sonication assays: ➥ ➥ endocytic tracer ➥ ➥ ➥ ➥ ➥ ➥ proteins ➥ AZ ➥ ➥ ➥ ➥ ➥ ➥ phospholipids ➥ D. Tyteca - PhD Thesis December 4th, 2001 16

  17. AZ slows down fluid-phase endocytosis control cells cells pretreated with AZ D. Tyteca - PhD Thesis December 4th, 2001 17

  18. Inhibition of fluid-phase endocytosis correlates with AZ content but is independent of phospholipidosis D. Tyteca - PhD Thesis December 4th, 2001 18

  19. AZ causes a major reduction of the number of endosomes and lysosomes and impairs accessibility of HRP to swollen and overloaded endosomes/lysosomes 5 min HRP 2 h HRP CT 3 h AZ 3 days AZ D. Tyteca - PhD Thesis December 4th, 2001 19

  20. ➁ ➁ Is AZ specific to fluid-phase endocytosis ? ➁ ➁ Azithromycin inhibits clathrin-independent pinocytosis and slows down sequestration of ligand-receptor complexes into endocytic and recycling vesicles of J774 macrophages D. Tyteca, P. Van Der Smissen, M. Mettlen, F. Van Bambeke, P.M. Tulkens, M.- P. Mingeot-Leclercq & P.J. Courtoy Submitted for publication ● Selection of experimental system ● ● ● J774 mouse macrophages ➥ ➥ ➥ ➥ homogeneous cell line ➥ ➥ ➥ ➥ high endocytic activity ➥ ➥ well-characterized system for pinocytosis and phagocytosis ➥ ➥ ● Experimental tests ● ● ● ➥ ➥ ➥ ➥ fluid-phase endocytosis ➥ ➥ bulk-membrane endocytosis ➥ ➥ ➥ ➥ ➥ ➥ receptor-mediated endocytosis ➥ ➥ ➥ ➥ phagocytosis D. Tyteca - PhD Thesis December 4th, 2001 20

  21. Fluid-phase endocytosis ➥ HRP and lucifer yellow (LY) ➥ ➥ ➥ zipper HRP trigger non-coated LY coated pit (a) pit (Cupers et al, 1994; recycling Swanson et compartment al, 1987) early phagosome (b) sorting endosome late late phagosome endosome lysosome D. Tyteca - PhD Thesis December 4th, 2001 21

  22. AZ inhibits fluid-phase endocytosis and this inhibition is reversible AZ HRP LY D. Tyteca - PhD Thesis December 4th, 2001 22

  23. Bulk-membrane endocytosis ➥ ➥ N -rhodamine-phosphatidylethanolamine ( N -Rh-PE) ➥ ➥ zipper non-coated trigger coated pit (a) pit aggregates of recycling N -Rh-PE compartment early phagosome (Kok et al, 1990) sorting endosome late phagosome late endosome lysosome D. Tyteca - PhD Thesis December 4th, 2001 23

  24. 24 AZ slows down bulk-membrane endocytosis December 4th, 2001 D. Tyteca - PhD Thesis

  25. Receptor-mediated endocytosis ➥ ➥ ➥ ➥ 125 I-labelled transferrin (a) zipper Y Y Y Y Y Y Y Y Tf non-coated trigger coated pit Y TfR (b) pit Y Y Y recycling Y compartment (Cupers et al, 1994) (c) early Y Y phagosome Y Y Y Y YY sorting endosome late late phagosome endosome lysosome D. Tyteca - PhD Thesis December 4th, 2001 25

  26. AZ strongly decreases the surface-pool of transferrin receptors D. Tyteca - PhD Thesis December 4th, 2001 26

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend